No Adverse Affect in Clinical Outcome Using Low Preablation Diagnostic 131I Activity in Differentiated Thyroid Cancer: Refuting Thyroid-Stunning Effect
BK Yap, B Murby - The Journal of Clinical Endocrinology & …, 2014 - academic.oup.com
Context: Published studies of thyroid stunning due to preablation 131I scanning in the
treatment of differentiated thyroid cancer after thyroidectomy had shown inconsistent clinical …
treatment of differentiated thyroid cancer after thyroidectomy had shown inconsistent clinical …
Long-Term Survival in Differentiated Thyroid Cancer Is Worse After Low-Activity Initial Post-Surgical 131I Therapy in Both High- and Low-Risk Patients
FA Verburg, U Mäder, C Reiners… - The Journal of Clinical …, 2014 - academic.oup.com
Context: Recent trial results have revived interest in low-activity initial 131I therapy (RIT) of
differentiated thyroid cancer (DTC). Objective: This study sought to compare different initial …
differentiated thyroid cancer (DTC). Objective: This study sought to compare different initial …
Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole‐body …
M Salvatori, G Perotti, V Rufini… - Clinical …, 2004 - Wiley Online Library
Summary objective To evaluate the risk of performing inappropriate 131I ablative therapies
for thyroid carcinoma in patients lacking thyroid remnants or metastases, using a strategy of …
for thyroid carcinoma in patients lacking thyroid remnants or metastases, using a strategy of …
Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients
FA Verburg, B de Keizer, CJM Lips… - European Journal of …, 2005 - academic.oup.com
Objectives Currently, little is known about the prognostic significance of achieving successful
ablation with the first dosage of I-131 in patients with differentiated thyroid cancer. This study …
ablation with the first dosage of I-131 in patients with differentiated thyroid cancer. This study …
Influence of 131I diagnostic dose on subsequent ablation in patients with differentiated thyroid carcinoma: discrepancy between the presence of visually apparent …
YH Hu, PW Wang, ST Wang, CH Lee… - Nuclear medicine …, 2004 - journals.lww.com
Background In the management of patients with differentiated thyroid carcinoma, direct
comparison of the presence of scintigraphic stunning after a diagnostic dose of 131 I with …
comparison of the presence of scintigraphic stunning after a diagnostic dose of 131 I with …
The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131I
FA Verburg, RBT Verkooijen… - Nuklearmedizin …, 2009 - thieme-connect.com
Objective: Dosimetry studies have shown that activities of 131 I as small as 10-20 MBq may
cause a stunning effect. A result of this stunning effect may be a lower success rate of the …
cause a stunning effect. A result of this stunning effect may be a lower success rate of the …
[HTML][HTML] TSH≥ 30 mU/L may not be necessary for successful 131I remnant ablation in patients with differentiated thyroid cancer
N Ju, L Hou, H Song, Z Qiu, Y Wang… - European Thyroid …, 2023 - etj.bioscientifica.com
Purpose To determine whether thyroid-stimulating hormone level≥ 30 mU/L is necessary
for radioiodine (131 I) remnant ablation (RRA) in patients with differentiated thyroid cancer …
for radioiodine (131 I) remnant ablation (RRA) in patients with differentiated thyroid cancer …
Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the …
Objective To investigate predictors for successful ablation and disease-free status after high-
dose radioiodine therapy in patients with differentiated thyroid cancer. Methods We enrolled …
dose radioiodine therapy in patients with differentiated thyroid cancer. Methods We enrolled …
The outcome of I-131 ablation therapy for intermediate and high-risk differentiated thyroid cancer using a strict definition of successful ablation
K Watanabe, M Uchiyama, K Fukuda - Japanese Journal of Radiology, 2017 - Springer
Purpose This article examines the outcome of radioactive iodine ablation therapy for thyroid
cancer in high-risk patients and investigates background factors influencing ablation failure …
cancer in high-risk patients and investigates background factors influencing ablation failure …
In patients with low-to intermediate-risk thyroid cancer, a preablative thyrotropin level of 30 μIU/mL is not adequate to achieve better response to 131I therapy
T Zhao, J Liang, Z Guo, T Li, Y Lin - Clinical nuclear medicine, 2016 - journals.lww.com
Purpose The optimal preablative level of thyrotropin (TSH) for patients with differentiated
thyroid cancer (DTC) to achieve better response after 131 I ablation remains unknown. The …
thyroid cancer (DTC) to achieve better response after 131 I ablation remains unknown. The …
相关搜索
- thyroid cancer 131i therapy
- adverse affect 131i activity
- 131i ablation diagnostic activity
- thyroid cancer adverse affect
- adverse affect clinical outcome
- clinical outcome 131i activity
- thyroid cancer successful ablation
- thyroid cancer body scan
- thyroid cancer clinical outcome
- thyroid cancer thyrotropin level
- thyroid cancer prognostic implication
- thyroid cancer risk profile
- thyroid cancer early prediction
- thyroid cancer 131i activity
- mbq 131i diagnostic activity
- thyroid cancer ablation therapy